-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Segments
-
Pharmaceutical
-
Consumer Health
-
MedTech
-
Public Health & Government
-
Payer & Provider
Pharmaceutical (Global page)
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Consumer Health
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
MedTech
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Payer & Provider
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreHealthcare Provider Solutions
Solutions
-
Research & Development
-
Real World Evidence
-
Information Insights
-
Market Research
-
Strategy Consulting
-
Contract Sales & Medical Solutions
-
Patient Solutions
-
AI, Digital & Technology Solutions
Research & Development (Global page)
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Real World Evidence
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Information Insights
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Market Research
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Strategy Consulting (Global page)
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORERelated Solutions
Contract Sales & Medical Solutions (Global page)
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
Patient Solutions (Global page)
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
AI, Digital & Technology Solutions
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREOur Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
Blog
Real World Evidence for MedTech, what is the right approach?
Jul 24, 2020
The concepts and value of Real World Evidence (RWE) are well-established, but RWE evolves as the data sources available expand. There are ‘conventional’ sources such as electronic health records, patient registries, and national claim databases; and ‘newer’ data sources such as mobile apps, wearables and social media. Digital and technology are at the forefront of the healthcare industry right now, as the solution to many of the challenges rising from the COVID-19 pandemic. Medical Technology (MedTech) is at the centre of the ‘Internet of Medical Things’ data production, whether as Digital Therapeutics (DTx) or in any given hospital with patients connected to multiple devices. The use of RWE for MedTech is receiving more attention, but the application is still relatively limited.
In many APAC countries, there are no specific MedTech requirements or guidelines on the use of RWE for regulatory approval, HTA or reimbursement. RWE continues to be perceived as “a nice to have” or “supportive” evidence. RWE can be used to address common challenges, such as the evidence gap from being unable to conduct randomized control trials (RCT). RWE can be used to justify the reimbursement price of new products, mitigate the risk of delayed product launches and strengthen product value proposition. Nevertheless, I frequently hear from MedTech players: “where do we begin?”. Here are steps to be considered:
- Understand the product value proposition, especially for different stakeholders. This will shape the research questions for the right study design
- Identify appropriate real world data (RWD) sources. These can be secondary or primary data depending on the research objectives.
- Create an operational plan to ensure the quality of evidence, including feasibility assessments for data sources
Many companies have had to adapt research operation approaches due to the impact of COVID-19. Remote monitoring, online data collection, virtual investigator meetings, have been demonstrated as useful approaches. These will become the “new normal” practice for RWE in the future and will further add to the huge amounts of RWD the healthcare ecosystem generates.
Preparing for RWE requires early and sustained commitment, with efforts starting at least 1-2 years before launch and reimbursement. New challenges will constantly arise in healthcare and the need to drive human health forward will continue. The need to draw insights from RWE will only increase.
Authors:
Sirinthip Petcharapiruch, Principal, Real World Solutions, Asia Pacific
Ruthie Burr, Consultant, Strategic Marketing and Business Development, Asia Pacific
For more information, please feel free to contact us.